Skip to main content
Premium Trial:

Request an Annual Quote

Bruker, Cellenion Ink Comarketing Agreement for Single-Cell Proteomics

NEW YORK – Cellenion said Tuesday that it has entered a comarketing agreement with Bruker around tools for single-cell proteomics experiments.

Under the agreement, the companies will pair Lyon, France-based Cellenion's cellenOne single-cell isolation and dispensing system with Bruker's timsTOF SCP mass spectrometer to enable label-free single-cell proteomics workflows.

Cellenion's cellenOne system provides high-throughput image-based dispensing of individual cells from cell suspensions and precision dispensing of reagents to automate and miniaturize sample preparation prior to single-cell analyses, while Bruker's timsTOF SCP is specifically designed for mass spec analyses of extremely small samples, down to the single-cell level.

"We believe our expertise in precision dispensing and platform technology … and Bruker’s expertise in developing mass spectrometers such as the timsTOF SCP for single-cell proteomics are a perfect match," Holger Eickhoff, CEO of Cellenion, said in a statement.

"This partnership of unique technologies provides our users with the ability to simplify and standardize single-cell 4D-proteomics workflows," said Rohan Thakur, executive vice president of life sciences mass spectrometry at Bruker. "This is important because it allows researchers to contrast knowledge learned from decades of bulk proteomics to new discoveries being made in single-cell proteomics using the cellenOne together with the timsTOF SCP system."

Financial terms of the deal were not disclosed.

On Monday, Cellenion announced a similar comarketing agreement for single-cell proteomics with Thermo Fisher Scientific.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.